Ullas Kamath

In an interaction with Moneycontrol, Ullas Kamath talks about the impact of the COVID-19 pandemic on the company’s product portfolio which includes products such Pril dishwashing liquid and Ujala fabric whitener.

Well rounded, forward looking Budget 2016: Ullas Kamath

Measures such as no change in service tax, reduced corporate tax for new companies and ease of doing business for new age start ups are definitely encouraging are sure to spur consumption led growth in the country, says Ullas Kamath, Joint Managing Director, Jyothy Laboratories.

FY15 revenue growth seen at 20%: Jyothy Laboratories

We expect 15-20 percent EBITDA in laundry service eventually, Ullas Kamath, joint managing director of Jyothy Laboratories said.

Hope to maintain 15% EBITDA margin going ahead: Jyothy Labs

FMCG player Jyothy Labs reported a 63.11 percent increase in its standalone net profit to Rs 27.37 crore for the third quarter ended December 31, 2013.

Debt-free Jyothy Labs reveals its acquisition plans

Speaking to CNBC-TV18, Ullas Kamath, joint managing director, Jyothy Labs says the company now has a was chest of Rs 250 crore which the pharma company will use to expand inorganically.

Expect topline to grow by 22-25% in FY14: Jyothy Lab

Ullas Kamath, Joint Managing Director says the company will stick to its guidance of 20-25 percent topline growth and 14-15 percent EBITDA for full fiscal year.

Will maintain 20-25% topline growth for FY14: Jyothy Labs

According to Ullas Kamath, the company is seeing robust volume growth in the semi urban and rural and will hold on to its guidance of 20 percent upward on the topline growth for FY14.

Will achieve guidance despite stiff competition: Jyothy Lab

Jyothy Laboratories today posted two-fold increase in net profit to Rs 28.70 crore for the first quarter ended June 30, 2013. Ullas Kamath, Joint Managing Director of the company told CNBC-TV18 that it has given the guidance of 20-25 percent on topline and 15 percent EBITDA margins.

Expect 14-15% EBITDA margins for FY14: Jyothy Labs

For Jyothy Labs they have a fantasttic team in place, products in place, integration too is complete and good cash flows too are coming in, therefore they are now ready to do their best, adds Ullas Kamath of Jyothy Laboratories.

Jyothy Labs expects 25% sales growth in FY14

Soaps and detergent maker Jyothy Laboratories expects its topline to rise 25 percent year-on-year in FY2014, as it expands into new geographies and products, Ullas Kamath, Joint MD, said on Friday.

Jyothy Labs' foreign acquisition

Jyothy Laboratories’ founder M.P. Ramachandran and deputy Ullas Kamath held on for a decade to pocket the failing Indian unit of Germany’s Henkel.

Margin pressure likely to continue: Jyothy Laboratories

Jyothy Laboratories has announced its results for the quarter ended December 2010. It has reported net profit of Rs 16.89 crore as against Rs 16.84 crore (YoY).